BioGend Therapeutics
TWD22.00
0
-TWD1.00-4.35% 05:30 Today
Statistics
Day High
23
Day Low
21
52W High
44.6
52W Low
21
Volume
162,447
Avg. Volume
77,159
Mkt Cap
2.95B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Nov 5Expected
Q1 2026
Q2 2026
Next
-0.17
-0.16
-0.14
-0.13
Expected EPS
-0.14287826952
Actual EPS
N/A
Financials
-38.05%Profit Margin
Unprofitable222.34MRevenue
-84.61MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
This company specializes in the development of innovative regenerative bio-orthopedic products. Its current pipeline includes BiG-001 and BiG-006, both of which are osteoinductive bone graft substitutes. Additionally, it is advancing BiG-009, an autologous cartilage repair system. Established in 2016, the firm's operations are based in Taipei, Taiwan.
Show More
CEO
Te-Li Chen
Employees
34
Country
Taiwan
ISIN
TW0006733009
Listings
0 Comments
Share your thoughts
FAQs
What is BioGend Therapeutics stock price today?▼
The current price of 6733.TWO is TWD22.00 TWD — it has decreased by -4.35% in the past 24 hours. Watch BioGend Therapeutics stock price performance more closely on the chart.
What is BioGend Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange BioGend Therapeutics stocks are traded under the ticker 6733.TWO.
Is BioGend Therapeutics stock price growing?▼
6733.TWO stock has fallen by -5.58% compared to the previous week, the month change is a -12.35% fall, over the last year BioGend Therapeutics has showed a -48.6% decrease.
What is BioGend Therapeutics market cap?▼
Today BioGend Therapeutics has the market capitalization of 2.95B
When is the next BioGend Therapeutics earnings date?▼
BioGend Therapeutics is going to release the next earnings report on November 5, 2026.
What is BioGend Therapeutics revenue for the last year?▼
BioGend Therapeutics revenue for the last year amounts to 222.34M TWD.
What is BioGend Therapeutics net income for the last year?▼
6733.TWO net income for the last year is -84.61M TWD.
How many employees does BioGend Therapeutics have?▼
As of November 3, 2026, the company has 34 employees.
In which sector is BioGend Therapeutics located?▼
BioGend Therapeutics operates in the Health & Wellness sector.
When did BioGend Therapeutics complete a stock split?▼
BioGend Therapeutics has not had any recent stock splits.
Where is BioGend Therapeutics headquartered?▼
BioGend Therapeutics is headquartered in Taipei, Taiwan.